Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Ultromics
Ultromics is transforming the detection of heart failure using artificial intelligence for echocardiography.
Ultromics
Ultromics is transforming the detection of heart failure using artificial intelligence for echocardiography.
TL;DR
Founded: 2017 (University of Oxford spin-out)
Product: EchoGo® AI software for automated echocardiogram analysis (FDA-cleared, CE-marked)
Focus: AI diagnostics for heart failure phenotypes and cardiac amyloidosis
Employees (approx.): 69
Known funding: $58.8M total (records through 2021); notable rounds include $33M Series B (2021) and $55M Series C (announced 2025)
Company Overview
Problem Domain
Cardiovascular diagnostics; detection of heart failure phenotypes (including HFpEF) and cardiac amyloidosis from echocardiography.
Founded
2017
Industry
Healthtech / Medical AI
Funding Track Record
$33,000,000
Series B reported as $33M (2021)
$55,000,000
Series C announced July 31, 2025
Investor Signal
“Backed by institutional investors including Oxford Science Enterprises, GV, Blue Venture Fund, Optum Ventures, and later participation/co-leads such as Legal & General, Allegis Capital and Lightrock”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,600+
New This Week